Catalyst Pharmaceuticals Inc
NASDAQ:CPRX 4:00:00 PM EDT
| Market Cap (Intraday) | 2.65B |
| Current PE | 13.41 |
| Forward PE | 14 |
| 2yr Forward PE | 11.99 |
| 10-Day MA | $22.41 |
| 50-Day MA | $23.81 |
| 200-Day MA | $22.34 |
Catalyst Pharmaceuticals Inc Stock, NASDAQ:CPRX
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134
United States of America
Phone: +1.305.420.3200
Number of Employees: 181
Description
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.